Metabolism and muscle recovery after an ICU stay
Official title: Characterisation of the Inflammatory, Metabolic, and Mitochondrial Profiles in the Context of Post-Intensive Care Muscle Dysfunction
Run by University of Liege · NCT07329530 · Data updated 2026-11-12
We will test whether blood and muscle metabolic and inflammatory markers can help predict how well adults recover muscle strength over three months after an ICU stay or major abdominal surgery.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of Liege Academic / other |
| Locations | 1 site (Liège) |
| Status | Recruiting |
| Started | December 1, 2025 |
| Main results expected | December 31, 2028 |
| Study ends | April 1, 2029 |
| Registry record updated | January 12, 2026 |
| Trial ID | NCT07329530 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults who survived a critical illness with an anticipated ICU stay of at least seven days or adults undergoing elective major abdominal surgery who can provide informed consent are ideal candidates.
✕Probably not a fit
Patients with active malignancy, known muscle or inherited metabolic disorders, pregnancy, inability to consent, or contraindications to muscle biopsy, bioelectrical impedance, or indirect calorimetry are unlikely to benefit from participation.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This single-center study recruits adults who survived a critical illness with an anticipated ICU stay of seven days or more and elective major abdominal surgery patients as a comparison group. Investigators will collect blood samples for inflammation markers, nucleosomes, erythrocyte membrane fatty acids, and myokines, and measure resting energy expenditure. Muscle performance will be measured at discharge and followed over three months, with muscle biopsies, bioelectrical impedance, and indirect calorimetry used when feasible. The goal is to link metabolic and neuroendocrine profiles to trajectories of muscle function after ICU discharge.
Why it matters
Potential benefit: If successful, the results could help identify patients at high risk for prolonged muscle weakness so they can receive earlier or more targeted rehabilitation.
How similar studies have gone: Prior studies have shown persistent inflammation and associations with ICU-acquired muscle weakness, but comprehensive metabolic and myokine profiling to predict individual recovery trajectories is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria * Critical illness: * anticipated ICU stay \>= 7 days * Major abdominal surgery * elective surgery Exclusion Criteria: * Active malignancy * Inherited metabolic disorder * Known muscle disease * Pregnancy * Patient refusal * Patient unable to express informed consent (dementia, confusion) * Known coagulation disorder (cirrhosis, genetic coagulopathy) or thrombocytopenia \< 100,000/mm³ on the day of biopsy, anemia with hemoglobin \< 9 g/dL on the day of biopsy, or treatment with anticoagulant agents (contraindication to muscle biopsies only) * Pacemaker or other implanted electronic device (contraindication to bioelectrical impedance analysis only) * Oxygen therapy (contraindication to indirect calorimetry during spontaneous ventilation)
Where it's running
-
CHU Sart Tilman
Liège, Belgium Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Predicting Extubation Problems With Machine Learning
This study tests whether computer models can predict extubation failure in adults on ventilators in the ICU.
-
Levetiracetam Dosing in Critically Ill on CRRT
This study tests how levetiracetam behaves in the bodies of adults on continuous renal replacement therapy to help figure out the best dosing.
-
Respiratory Physiotherapy in Critically Ill Pneumonia Patients
This study tests whether a structured breathing and chest therapy program can change inflammatory biomarkers in adults with pneumonia in the ICU compared to usual care.
-
Immersive VR for improving upper limb function in critically ill ICU patients
This trial tests whether fully immersive virtual reality training added to standard ICU rehabilitation can help improve upper limb strength and coordination in adults with ICU-acquired weakness.
-
Cycling with immersive VR for ICU patients recovering from critical illness
In this crossover study, critically ill adults in the ICU will try three 10-minute cycling sessions to see if an immersive VR environment motivates them more than cycling with no visuals or cycling while watching a route on a TV.
-
Factors Influencing Outcomes in ECMO and Impella Patients
This study tests whether metabolic and thyroid hormone changes help predict survival for adults on ECMO or Impella at a single Hungarian cardiac ICU.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.